As part of efforts on Tuesday, May 13, CBL presented its ambitious five-year Strategic Plan, covering 2025-2029, worth USD$ 63.32 million before partners in the sector.

Google Updates Iconic 'G' Logo After Nearly 10 Years The updated "G" logo has a gradient effect now, which could be an attempt to better sync design with the company's AI products.

CBL Properties announced results for the first quarter ended March 31. During Q1 2025, CBL closed on dispositions representing more than $73.3 million of gross proceeds at CBL's share, including ...

CHATTANOOGA, Tenn., May 01, 2025--CBL Properties (NYSE:CBL) today announced that its Board of Directors authorized a stock repurchase program for the Company to buy up to $25 million of its common ...

CBL International Limited (NASDAQ: BANL) Q4 2024 Results Conference Call April 16, 2025 10:00 PM ET Company Participants Venus Zhao - IR & Public Relations Director Teck Lim Chia - Chairman & CEO ...

About CBL Properties Headquartered in Chattanooga, TN, CBL Properties owns and manages a national portfolio of market-dominant properties located in dynamic and growing communities.

CHATTANOOGA, Tenn., February 25, 2025--CBL Properties (NYSE: CBL) today announced several promotions including one promotion to Senior Vice President and five new Vice Presidents.

Valuation CBL's valuation remains very cheap, at only 4.26x my expected 2025 AFFO of $7.20/share, notwithstanding the still substantial portion of net debt in the company's capital structure.

16:57 EST CBL International (BANL) files $50M mixed securities shelfStay Ahead of the Market:Discover outperforming stocks and invest smarter wi ...

Previously, the company expected earnings in the range of $6.28 to $6.72 per share and adjusted FFO in the range of $0.08 to $0.52 per share. On Thursday, CBL announced that its Board of Directors ...

CBL, which may be transcriptionally regulated by HOXB13 and post-transcriptionally regulated by miR-1321, was identified as the most promising potential biomarker for AD.

Results: CBL-B deficiency suppressed tumor growth in mouse tumor models and enhanced cytokines release in T cells upon TCR engagement. CBL-B inhibitor, YF550-C1, alleviated PGE2-mediated ...